What Does the Overturning of Chevron Mean for Healthcare?

Lexology July 3, 2024
Holland & Knight LLP

Highlights

• The U.S. Supreme Court’s recent ruling to upend the Chevron deference will likely have a significant impact on the healthcare industry.
• In overturning Chevron, the Supreme Court emphasized that statutory interpretation is fundamentally a judicial responsibility.
• The decision could have significant implications for several agencies, including the U.S. Department of Health and Human Services (HHS), the U.S. Food and Drug Administration (FDA), the HHS Office of Civil Rights (OCR) and the Centers for Medicare & Medicaid Services (CMS).

The U.S. Supreme Court issued a significant ruling on June 28, 2024, that changes the respective roles of administrative agencies and the courts in interpreting statutes. In Loper Bright Enterprises v. Raimondo, the court voted 6-3 to overturn its...

Today's Sponsors

Today's Sponsor